7lct: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==Improved Feline Drugs as SARS-CoV-2 Mpro Inhibitors: Structure-Activity Studies & Micellar Solubilization for Enhanced Bioavailability== | |||
<StructureSection load='7lct' size='340' side='right'caption='[[7lct]]' scene=''> | |||
== Structural highlights == | |||
<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7LCT OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7LCT FirstGlance]. <br> | |||
</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7lct FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7lct OCA], [https://pdbe.org/7lct PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7lct RCSB], [https://www.ebi.ac.uk/pdbsum/7lct PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7lct ProSAT]</span></td></tr> | |||
[[ | </table> | ||
[[ | __TOC__ | ||
[[Category: | </StructureSection> | ||
[[Category: Arutyunova | [[Category: Large Structures]] | ||
[[Category: Lemieux | [[Category: Arutyunova E]] | ||
[[Category: Khan MB]] | |||
[[Category: Lemieux MJ]] | |||
[[Category: Young HS]] | |||
Revision as of 09:57, 7 July 2021
Improved Feline Drugs as SARS-CoV-2 Mpro Inhibitors: Structure-Activity Studies & Micellar Solubilization for Enhanced Bioavailability
| ||||||||||||
